Natick, MA, United States of America

Anna M Mahr


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 40(Granted Patents)


Company Filing History:


Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Spotlight: Anna M. Mahr and Her Contribution to DNA Detection

Introduction: Anna M. Mahr, an accomplished inventor based in Natick, MA, has made a significant mark in the field of biotechnology with her innovative methods of detecting cellular material. With a focus on enhancing DNA detection techniques while preserving cellular morphology, her work stands at the intersection of rapid diagnostics and cell analysis.

Latest Patents: Anna M. Mahr holds a patent for a "Method of Detecting Cellular Material." This inventive method introduces a rapid procedure for detecting DNA within a cell, ensuring that the nucleus's morphology is retained for subsequent analysis. The process involves depositing a cell on a polymeric membrane filter, where the DNA is retained and made available for binding with a fluorescently-labeled nucleic acid probe. By incubating this filter with the labeled probe, the presence of DNA can be detected efficiently without requiring separate permeabilization steps. This method's simplicity and speed make it particularly applicable to sample volumes commonly found in clinical laboratories.

Career Highlights: Anna Mahr is currently associated with Genzyme Corporation, a renowned entity in biotechnology and genetics. Her inventive contributions have not only showcased her technical expertise but have also highlighted her commitment to advancing diagnostic methods and clinical procedures.

Collaborations: Throughout her career, Anna has collaborated with notable colleagues, including Ann E. Bowe and Alyson L. Ruff-Roberts. These partnerships have undoubtedly fostered an environment of innovation and creativity that drives advancements in the field of biotechnology.

Conclusion: Anna M. Mahr's work exemplifies the vital role of inventors in enhancing scientific methodologies. Her patented method for DNA detection bridges the gap between rapid diagnostics and cellular analysis, paving the way for improved clinical outcomes. As she continues her groundbreaking work at Genzyme Corporation, her contributions remain an inspiring reminder of the power of innovation in health and science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…